Newsroom
$1.2M to advance the treatment of pancreatic cancer
avril 2, 2014
The Canadian Cancer Society has awarded Dr. John Bell an Impact Grant totalling $1.2 million over the next five years to further his research into the use of viruses to fight pancreatic cancer, one of the deadliest forms of cancer. According to the Canadian Cancer Society, an estimated 4,700 people in this country were diagnosed with pancreatic cancer in 2013 and 4,300 people died of the disease. The five-year relative survival rate of pancreatic cancer is only eight per cent. A world leader in oncolytic viruses, Dr Bell’s work has the potential to result in a highly targeted therapy for pancreatic cancer with fewer side effects than current treatment methods. See details in the Canadian Cancer Society news release or article in the Ottawa Citizen .
About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.
Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)
padmoore@ohri.ca
